Cary Street Partners Investment Advisory’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
GIM
Cary Street Partners Investment Advisory's STE Position: Q2 2026 in Review
Cary Street Partners Investment Advisory increased its Steris (STE) stake by 6.1% in Q2 2026, buying an estimated $22.7K and bringing the position to 1,833 shares worth $386K. The position accounts for 0.08% of the portfolio, ranked #238.
Cary Street Partners Investment Advisory first reported a position in STE in Q2 2022 and has held it in 16 quarters since. The position peaked at $508K in Q3 2024. 522 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Cary Street Partners Investment Advisory held 1,833 shares of Steris worth $386K as of Q2 2026.
- Cary Street Partners Investment Advisory bought 106 Steris shares in Q2 2026, an estimated $22.7K.
- Steris made up 0.08% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #238 holding.
- Cary Street Partners Investment Advisory first reported a position in Steris in Q2 2022 and has held it in 16 quarters since.
- Cary Street Partners Investment Advisory's Steris position peaked at $508K in Q3 2024.
- 522 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.